According to a market report by Lucintel, the future of the global neohesperidine DC market looks promising with opportunities in the food, chemical industry, and medicine markets. The global neohesperidine DC market is expected to grow with a CAGR of 4.9% from 2024 to 2030. The major drivers for this market are rising demand for natural sweeteners, expanding preference for low-calorie and sugar-free products, and growing demand for functional foods and nutraceuticals.
more than 150 – page report is developed to understand Trends, opportunity and forecast in neohesperidine DC market to 2030 by product type (food grade, industrial grade, and pharmacy grade), end use (food, chemical industry, and medicine), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, food grade, industrial grade, & pharmacy grade are the major segments of neohesperidine DC market by product type. Lucintel forecasts that food grade is expected to witness the highest growth.
Within this market, food is expected to witness the highest growth.
Download sample by clicking on neohesperidine DC market
North America is expected to witness highest growth.
haanxi Huike Botanical Development, Chengdu Okay, Guangzhou HanFang Pharmaceutical, Nutrafur, Hunan Huakang, Interquim, Layn, Shaanxi NHK Technology, Guangxi Gaotong Food Technology, and Changsha Sunnycare are the major suppliers in the neohesperidine DC market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]